Indian Share Market Tips- Strides Pharma up 3% on successful USFDA inspection of Bangalore unit
The inspection was completed successfully with Zero 483 observations.
The share price of Strides Pharma Science added 3 percent in the early trade on Monday on successful completion of USFDA inspection of Bangalore unit.
The company's formulations facility in Bangalore recently underwent a USFDA inspection that ended on November 2, 2018. The inspection was completed successfully with Zero 483 observations, the company said in a release.
The facility (KRS Gardens) in Bangalore is the largest facility for the company and has the capability in several dosage formats including tablets, capsules (both hard gelatin and soft gelatin), ointments, creams, and liquids.
The facility supports several important current and future submissions for the US market.
Strides Pharma Science: Company announced the successful completion of US FDA inspection at its flagship facility in Bangalore with zero 483 observations.
Strides Pharma Science was quoting at Rs 429.55, up Rs 9.75, or 2.32 percent on the BSE.
A Special Offer for a Special Diwali! Get 20 % off Monthly and Quarterly Or 40 % off half-yearly or yearly Services. Click here or watch More Offers- Indian Share Market Tips
0 comments